BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26179426)

  • 21. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
    Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
    Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
    Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
    J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
    Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
    Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
    Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
    Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein O-fucosyltransferase 1: a potential diagnostic marker and therapeutic target for human oral cancer.
    Yokota S; Ogawara K; Kimura R; Shimizu F; Baba T; Minakawa Y; Higo M; Kasamatsu A; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    Int J Oncol; 2013 Dec; 43(6):1864-70. PubMed ID: 24064921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematogenous cytokeratin 20 mRNA detection has prognostic impact in oral squamous cell carcinoma: preliminary results.
    Toyoshima T; Vairaktaris E; Nkenke E; Schlegel KA; Neukam FW; Ries J
    Anticancer Res; 2009 Jan; 29(1):291-7. PubMed ID: 19331164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.
    Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M
    Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
    Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complex-I Alteration and Enhanced Mitochondrial Fusion Are Associated With Prostate Cancer Progression.
    Philley JV; Kannan A; Qin W; Sauter ER; Ikebe M; Hertweck KL; Troyer DA; Semmes OJ; Dasgupta S
    J Cell Physiol; 2016 Jun; 231(6):1364-74. PubMed ID: 26530043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
    Pramanik KK; Nagini S; Singh AK; Mishra P; Kashyap T; Nath N; Alam M; Rana A; Mishra R
    Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annexin A8 is a novel molecular marker for detecting lymph node metastasis in oral squamous cell carcinoma.
    Oka R; Nakashiro K; Goda H; Iwamoto K; Tokuzen N; Hamakawa H
    Oncotarget; 2016 Jan; 7(4):4882-9. PubMed ID: 26700817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma.
    Gissi DB; Morandi L; Gabusi A; Tarsitano A; Marchetti C; Cura F; Palmieri A; Montebugnoli L; Asioli S; Foschini MP; Scapoli L
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
    Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
    Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
    Jiang T; Liu G; Wang L; Liu H
    PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
    Koyama T; Ogawara K; Kasamatsu A; Okamoto A; Kasama H; Minakawa Y; Shimada K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
    Cancer Med; 2015 May; 4(5):759-69. PubMed ID: 25644496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell Carcinoma.
    Kloss-Brandstätter A; Weissensteiner H; Erhart G; Schäfer G; Forer L; Schönherr S; Pacher D; Seifarth C; Stöckl A; Fendt L; Sottsas I; Klocker H; Huck CW; Rasse M; Kronenberg F; Kloss FR
    PLoS One; 2015; 10(8):e0135643. PubMed ID: 26262956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of glutathione S-transferase pi correlates with poorly differentiated grade in patients with oral squamous cell carcinoma.
    Ma HL; Yu C; Liu Y; Tan YR; Qiao JK; Yang X; Wang LZ; Li J; Chen Q; Chen FX; Zhang ZY; Zhong LP
    J Oral Pathol Med; 2015 Mar; 44(3):193-200. PubMed ID: 25047743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
    Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
    Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.
    Ko HH; Cheng SL; Lee JJ; Chen HM; Kuo MY; Cheng SJ
    Head Neck; 2017 Jul; 39(7):1327-1332. PubMed ID: 28301069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LRP6 is identified as a potential prognostic marker for oral squamous cell carcinoma via MALDI-IMS.
    Yuan Y; Xie X; Jiang Y; Wei Z; Wang P; Chen F; Li X; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Wang Z; Chen Q
    Cell Death Dis; 2017 Sep; 8(9):e3035. PubMed ID: 28880263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.